ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

OGEN Oragenics Inc

1,02
-0,015 (-1,45%)
Nach Börsenschluss
Zuletzt aktualisiert: 01:25:28
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Oragenics Inc OGEN AMEX Common Stock
  Änderung Änderung % Aktuell Zeit
-0,015 -1,45% 1,02 01:25:28
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,01 1,00 1,04 1,02 1,035
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
19.4.202423:50BWOragenics, Inc. Announces Notification of Noncompliance with..
01.4.202415:05BWOragenics, Inc. Files 10K and Provides Company Update
18.3.202412:00BWOragenics Appoints James Kelly MD, Chief Medical Officer, to..
06.3.202422:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05.3.202413:45BWOragenics, Inc. Prepares Drug for Phase II Clinical Trials..
01.3.202422:04BWOragenics Announces Closing of Public Offering
29.2.202422:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.2.202415:03EDGAR2Form 8-K - Current report
28.2.202403:25BWOragenics Announces Pricing of Public Offering
27.2.202423:09EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
27.2.202423:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27.2.202422:33BWOragenics Announces Proposed Public Offering
13.2.202402:06EDGAR2Form SC 13D - General statement of acquisition of beneficial..
12.2.202422:45EDGAR2Form 8-K - Current report
12.2.202422:41BWOragenics, Inc. Announces Leadership Transition
07.2.202414:00EDGAR2Form 8-K - Current report
07.2.202414:00BWOragenics, Inc. Announces Expiration of Its Investment..
05.2.202414:00EDGAR2Form 8-K - Current report
05.2.202414:00BWOragenics, Inc. Preparing for Phase II Clinical Trials to..
23.1.202423:34BWOragenics Announces Termination of At-The-Market Offering..
23.1.202423:18EDGAR2Form 8-K - Current report
22.1.202423:30EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
16.1.202415:10EDGAR2Form 8-K - Current report
16.1.202415:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
16.1.202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10.1.202422:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
02.1.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202415:22EDGAR2Form 8-K - Current report
02.1.202413:30BWOragenics Completes Acquisition of Odyssey Health’s..
29.12.202313:30EDGAR2Form 8-K - Current report
15.12.202321:45EDGAR2Form 8-K - Current report
08.12.202322:00EDGAR2Form 8-K - Current report
01.12.202323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202323:50EDGAR2Form 144 - Report of proposed sale of securities
20.11.202321:45EDGAR2Form 8-K - Current report
16.11.202320:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02.11.202312:00EDGAR2Form 8-K - Current report
02.11.202312:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02.11.202312:00BWOragenics Issues Update to Shareholders
30.10.202321:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30.10.202321:00EDGAR2Form DEF 14A - Other definitive proxy statements
18.10.202314:30BWOragenics Announces Appointment of Bruce Cassidy and John..
06.10.202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202322:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.10.202322:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.10.202323:29EDGAR2Form 8-K - Current report
05.10.202312:30EDGAR2Form 8-K - Current report
05.10.202312:30BWOragenics to Acquire Odyssey Health’s Neurological Drug..
29.9.202322:00EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock